Do analysts prefer ORGS or MEHA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orgenesis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is ORGS or MEHA more profitable?

Functional Brands has a net margin of 0.00% compared to Orgenesis' net margin of -3,827.81%. Company Net Margins Return on Equity Return on Assets Orgenesis -3,827.81% N/A -130.18% Functional Brands N/A N/A N/A

Do analysts recommend WINT or MEHA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Windtree Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is WINT or MEHA more profitable?

Functional Brands' return on equity of 0.00% beat Windtree Therapeutics' return on equity. Company Net Margins Return on Equity Return on Assets Windtree Therapeutics N/A -207.34% -50.19% Functional Brands N/A N/A N/A

Do analysts prefer HEPA or MEHA?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hepion Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is HEPA or MEHA more profitable?

Functional Brands' return on equity of 0.00% beat Hepion Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Hepion Pharmaceuticals N/A -812.56% -207.31% Functional Brands N/A N/A N/A

Do analysts prefer CERO or MEHA?

CERo Therapeutics presently has a consensus price target of $30.00, indicating a potential upside of 272,627.27%. Given CERo Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe CERo Therapeutics is more favorable than Functional Brands. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CERo Therapeutics 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is CERO or MEHA more profitable?

Company Net Margins Return on Equity Return on Assets CERo Therapeutics N/A N/A -209.40% Functional Brands N/A N/A N/A

Do analysts prefer MEHA or BPTSY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Functional Brands 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biophytis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation & earnings, MEHA or BPTSY?

Functional Brands has higher revenue and earnings than Biophytis. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Functional Brands $6.67M 0.03 $760K -$0.32 N/A Biophytis N/A N/A -$18.43M N/A N/A

Is MEHA or BPTSY more profitable?

Company Net Margins Return on Equity Return on Assets Functional Brands N/A N/A N/A Biophytis N/A N/A N/A

Functional Brands (MEHA) Competitors

$0.0043 0.00 (0.00%)

As of 07/17/2026 03:58 PM Eastern

Compare

MEHA vs. ORGS, WINT, HEPA, CERO, and BPTSY

Should you buy Functional Brands stock or one of its competitors? MarketBeat compares Functional Brands with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Functional Brands include Orgenesis (ORGS), Windtree Therapeutics (WINT), Hepion Pharmaceuticals (HEPA), CERo Therapeutics (CERO), and Biophytis (BPTSY). These companies are all part of the "pharmaceutical products" industry.

How does Functional Brands compare to Orgenesis?

Orgenesis (NASDAQ:ORGS) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

22.6% of Orgenesis shares are held by institutional investors. 1.9% of Orgenesis shares are held by insiders. Comparatively, 4.3% of Functional Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Orgenesis	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Functional Brands has a net margin of 0.00% compared to Orgenesis' net margin of -3,827.81%.

Company	Net Margins	Return on Equity	Return on Assets
Orgenesis	-3,827.81%	N/A	-130.18%
Functional Brands	N/A	N/A	N/A

In the previous week, Orgenesis' average media sentiment score of 0.00 equaled Functional Brands'average media sentiment score.

Company	Overall Sentiment
Orgenesis	Neutral
Functional Brands	Neutral

Functional Brands has higher revenue and earnings than Orgenesis. Functional Brands is trading at a lower price-to-earnings ratio than Orgenesis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Orgenesis	$662K	0.03	-$55.36M	-$11.51	N/A
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A

Summary

Functional Brands beats Orgenesis on 7 of the 10 factors compared between the two stocks.

How does Functional Brands compare to Windtree Therapeutics?

Windtree Therapeutics (NASDAQ:WINT) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, analyst recommendations, media sentiment, dividends, earnings and risk.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Windtree Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Functional Brands has higher revenue and earnings than Windtree Therapeutics. Functional Brands is trading at a lower price-to-earnings ratio than Windtree Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Windtree Therapeutics	N/A	N/A	-$1.79M	-$8.77	N/A
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A

29.3% of Windtree Therapeutics shares are owned by institutional investors. 0.2% of Windtree Therapeutics shares are owned by insiders. Comparatively, 4.3% of Functional Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Windtree Therapeutics' average media sentiment score of 0.00 equaled Functional Brands'average media sentiment score.

Company	Overall Sentiment
Windtree Therapeutics	Neutral
Functional Brands	Neutral

Functional Brands' return on equity of 0.00% beat Windtree Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Windtree Therapeutics	N/A	-207.34%	-50.19%
Functional Brands	N/A	N/A	N/A

Summary

Functional Brands beats Windtree Therapeutics on 7 of the 9 factors compared between the two stocks.

How does Functional Brands compare to Hepion Pharmaceuticals?

Hepion Pharmaceuticals (NASDAQ:HEPA) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

In the previous week, Hepion Pharmaceuticals' average media sentiment score of 0.00 equaled Functional Brands'average media sentiment score.

Company	Overall Sentiment
Hepion Pharmaceuticals	Neutral
Functional Brands	Neutral

17.2% of Hepion Pharmaceuticals shares are owned by institutional investors. 0.1% of Hepion Pharmaceuticals shares are owned by company insiders. Comparatively, 4.3% of Functional Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Functional Brands' return on equity of 0.00% beat Hepion Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hepion Pharmaceuticals	N/A	-812.56%	-207.31%
Functional Brands	N/A	N/A	N/A

Functional Brands has higher revenue and earnings than Hepion Pharmaceuticals. Functional Brands is trading at a lower price-to-earnings ratio than Hepion Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hepion Pharmaceuticals	N/A	N/A	-$48.93M	-$72.15	N/A
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hepion Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Functional Brands beats Hepion Pharmaceuticals on 8 of the 9 factors compared between the two stocks.

How does Functional Brands compare to CERo Therapeutics?

CERo Therapeutics (NASDAQ:CERO) and Functional Brands (NASDAQ:MEHA) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

In the previous week, CERo Therapeutics had 2 more articles in the media than Functional Brands. MarketBeat recorded 2 mentions for CERo Therapeutics and 0 mentions for Functional Brands. CERo Therapeutics' average media sentiment score of 0.59 beat Functional Brands' score of 0.00 indicating that CERo Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
CERo Therapeutics	Positive
Functional Brands	Neutral

Functional Brands has higher revenue and earnings than CERo Therapeutics. Functional Brands is trading at a lower price-to-earnings ratio than CERo Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CERo Therapeutics	N/A	N/A	-$8.30M	-$71.01	N/A
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A

Company	Net Margins	Return on Equity	Return on Assets
CERo Therapeutics	N/A	N/A	-209.40%
Functional Brands	N/A	N/A	N/A

CERo Therapeutics presently has a consensus price target of $30.00, indicating a potential upside of 272,627.27%. Given CERo Therapeutics' stronger consensus rating and higher probable upside, equities analysts plainly believe CERo Therapeutics is more favorable than Functional Brands.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CERo Therapeutics	1 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.67
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

29.6% of CERo Therapeutics shares are owned by institutional investors. 0.4% of CERo Therapeutics shares are owned by insiders. Comparatively, 4.3% of Functional Brands shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

CERo Therapeutics beats Functional Brands on 6 of the 11 factors compared between the two stocks.

How does Functional Brands compare to Biophytis?

Functional Brands (NASDAQ:MEHA) and Biophytis (NASDAQ:BPTSY) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Functional Brands has higher revenue and earnings than Biophytis.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Functional Brands	$6.67M	0.03	$760K	-$0.32	N/A
Biophytis	N/A	N/A	-$18.43M	N/A	N/A

In the previous week, Functional Brands' average media sentiment score of 0.00 equaled Biophytis'average media sentiment score.

Company	Overall Sentiment
Functional Brands	Neutral
Biophytis	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Functional Brands	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biophytis	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

0.1% of Biophytis shares are held by institutional investors. 4.3% of Functional Brands shares are held by insiders. Comparatively, 3.7% of Biophytis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Company	Net Margins	Return on Equity	Return on Assets
Functional Brands	N/A	N/A	N/A
Biophytis	N/A	N/A	N/A

Summary

Functional Brands beats Biophytis on 4 of the 5 factors compared between the two stocks.

Get Functional Brands News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEHA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MEHA vs. The Competition

Export

Metric	Functional Brands	Medicinal Chemicals Industry	Manufacturing Sector	NASDAQ Exchange
Market Cap	$184K	$1.23B	$4.41B	$12.43B
Dividend Yield	N/A	N/A	34.29%	8.84%
P/E Ratio	-0.01	N/A	23.70	23.89
Price / Sales	0.03	2.13	135.46	90.49
Price / Cash	0.27	0.27	164.63	60.07
Price / Book	0.05	251.02	12.18	6.18
Net Income	$760K	-$1.41M	$121.47M	$331.73M
7 Day Performance	N/A	-6.61%	-1.03%	-2.04%
1 Month Performance	N/A	-34.67%	-2.53%	-2.14%
1 Year Performance	N/A	-65.38%	9.97%	17.28%

Functional Brands Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MEHA Functional Brands	0.3864 of 5 stars	$0.00 flat	N/A	N/A	$184K	$6.67M	N/A	33	Gap Down
ORGS Orgenesis	N/A	$0.37 +132.5%	N/A	-99.6%	$827K	$662K	N/A	150	Gap Up
WINT Windtree Therapeutics	N/A	$0.02 +6.6%	N/A	-98.7%	$724K	N/A	N/A	30	Gap Up
HEPA Hepion Pharmaceuticals	N/A	$0.06 -14.3%	N/A	+40.2%	$686K	N/A	N/A	20	Gap Up
CERO CERo Therapeutics	1.194 of 5 stars	$0.02 -10.2%	$30.00 +199,900.0%	-99.9%	$677K	N/A	N/A	8	News Coverage Gap Up High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MEHA) was last updated on 7/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Functional Brands (MEHA) Competitors

MEHA vs. ORGS, WINT, HEPA, CERO, and BPTSY

How does Functional Brands compare to Orgenesis?

Summary

How does Functional Brands compare to Windtree Therapeutics?

Summary

How does Functional Brands compare to Hepion Pharmaceuticals?

Summary

How does Functional Brands compare to CERo Therapeutics?

Summary

How does Functional Brands compare to Biophytis?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEHA vs. The Competition

Functional Brands Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Functional Brands (MEHA) Competitors

MEHA vs. ORGS, WINT, HEPA, CERO, and BPTSY

How does Functional Brands compare to Orgenesis?

Do insiders and institutionals believe in ORGS or MEHA?

Do analysts prefer ORGS or MEHA?

Is ORGS or MEHA more profitable?

Does the media prefer ORGS or MEHA?

Which has stronger earnings & valuation, ORGS or MEHA?

Summary

How does Functional Brands compare to Windtree Therapeutics?

Do analysts recommend WINT or MEHA?

Which has higher earnings & valuation, WINT or MEHA?

Do institutionals and insiders hold more shares of WINT or MEHA?

Does the media refer more to WINT or MEHA?

Is WINT or MEHA more profitable?

Summary

How does Functional Brands compare to Hepion Pharmaceuticals?

Does the media refer more to HEPA or MEHA?

Do institutionals and insiders have more ownership in HEPA or MEHA?

Is HEPA or MEHA more profitable?

Which has stronger valuation & earnings, HEPA or MEHA?

Do analysts prefer HEPA or MEHA?

Summary

How does Functional Brands compare to CERo Therapeutics?

Does the media favor CERO or MEHA?

Which has stronger valuation & earnings, CERO or MEHA?

Is CERO or MEHA more profitable?

Do analysts prefer CERO or MEHA?

Do institutionals & insiders believe in CERO or MEHA?

Summary

How does Functional Brands compare to Biophytis?

Which has preferable valuation & earnings, MEHA or BPTSY?

Does the media prefer MEHA or BPTSY?

Do analysts prefer MEHA or BPTSY?

Do institutionals and insiders believe in MEHA or BPTSY?

Is MEHA or BPTSY more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEHA vs. The Competition

Functional Brands Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools